Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115088
Chunk: 172

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 172
---
 and the fees and disbursements of our counsel and of our independent accountants and reasonable fees.

To the extent the Penny Warrants are exercised for cash, if at all, we will receive the exercise price of any such exercise of the Penny Warrants, but will not receive any proceeds from the sale of the shares of our Common Stock issuable upon such exercise. If all of the remaining Penny Warrants were exercised, we would receive gross proceeds of $65,000. However, the holders of the Penny Warrants are not obligated to exercise the Penny Warrants and we cannot predict whether or when, if ever, the holders of the Penny Warrants will choose to exercise the Penny Warrants, in whole or in part. Each Penny Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $0.01 per share.

We currently intend to use the proceeds (if any) from the exercise of the Penny Warrants for cash for working capital and general corporate purposes, which may include capital expenditures, commercialization expenditures, research and development expenditures, regulatory affairs expenditures, clinical trial expenditures, acquisitions of new technologies and investments, business combinations and the repayment, refinancing, redemption or repurchase of indebtedness or capital stock, although we believe we can fund our operations with cash on hand and from additional sources of financing that we may seek from time to time.However, we have not designated any specific uses and have no current agreement with respect to any acquisition or strategic transaction. As of the date of this prospectus, we cannot specify with certainty all of the particular uses, and the respective amounts we may allocate to those uses, for any proceeds we receive from the exercise of the Penny Warrants. Accordingly, we will retain broad discretion over the use of these proceeds. Pending our use of the proceeds as described above, we intend to invest such proceeds in interest-bearing instruments. There is no assurance that the holders of the Penny Warrants will elect to exercise any or all of such Penny Warrants. To the extent that the Penny Warrants are exercised on a “cashless basis,” the amount of cash we would receive from the exercise of the Penny Warrants will decrease.

<div align='center'>105</div>

### DETERMINATION OF OFFERING PRICE
We cannot currently determine the price or prices at which shares of our Common Stock may be sold by the Selling Stockholder under this prospectus.

<div align='center'>**106

MARKET INFORMATION FOR SECURITIES AND DIVIDEND POLICY**